Approximately one-third of hepatocellular carcinoma (HCC) patients exhibit serum alpha-fetal protein (AFP) negativity (Zhang et al., 2018), which is very common in cirrhotic patients (Ma, Wang & Teng, 2013), with small liver tumors being particularly prevalent in this group. The gene discussed is AFP; the disease is hepatocellular carcinoma.